Showing results (291-300 of 1,945) with videos related to

Sort By:
Pageof 195
RMD Open|January 6, 2026
Sjögren's disease metabolome reveals biomarker signatures to characterise patients and assess disease activityMadeleine Suffiotti, Lukas Tanner, Lukasz Kozera, et al.
RMD Open|January 22, 2026
Incidence rate and risk factors of arrhythmias in patients with psoriatic arthritisAbdulrahman Y Almansouri, Jiayi Li, Laura Bumbulis, et al.
RMD Open|December 31, 2025
Heterogeneity of antiphospholipid antibody profiles in a clinical cohort and association with distinct clinical featuresZhongjun Shen, Shuo Yang, Shangjia Jin, et al.
RMD Open|December 23, 2025
Global social media use among rheumatology professionals: the EULAR SoMeR Study Group surveyLatika Gupta, Manali Sarkar, Jeffrey Sparks, et al.
RMD Open|November 5, 2025
Long-term safety and efficacy of upadacitinib in Japanese patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: 5-year results from the SELECT-SUNRISE randomised controlled trialHideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka, et al.
RMD Open|October 28, 2025
Pre-eclampsia is more common in women with active psoriatic arthritis in pregnancy: a population-based studyCarina Gotestam Skorpen, Stian Lydersen, Kjell Åsmund Salvesen, et al.
RMD Open|October 31, 2025
Poor health-related quality of life despite Lupus Low Disease Activity State or Definitions of Remission in systemic lupus erythematosus (SLE) remission in patients with SLE: results from a clinical trial settingIoannis Parodis, Julius Lindblom, Leonardo Palazzo, et al.
RMD Open|October 23, 2025
Unravelling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrumKevin Chevalier, Benjamin Thoreau, Marc Michel, et al.
RMD Open|October 6, 2025
Polyclonal Vβ21.3 expansion in multisystem inflammatory syndrome in children despite SARS-CoV-2 vaccinationStejara Netea, Liliane Khoryati, Sietse Nagelkerke, et al.
RMD Open|October 6, 2025
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspectiveElena W Y Hsieh, James B Chung, Afsah Amin, et al.
Pageof 195